drugset / Trial / NCT01049685
Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Retrospective longitudinal cohort study with 36 HIV naïve-treatment patients, who started therapy with lopinavir/ritonavir or efavirenz (LPV/r or EFZ), follow-up of 36 months. Primary endpoint: virological success (HIV RNA \<50 copies/mL) in the first six months and at the end of the study.
Timeline
- Start
- 2006-08
- Primary completion
- 2009-12
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Efavirenz | Other / unclassified | 1 unknown | — |
| Comparator | Lopinavir/ritonavir | Unknown | 2 unknown | — |